About the study: In this nested case-control study, receiving a fecal immunochemical test was associated with a lower risk of overall death from colorectal cancer, particularly in the left colon, and the associations were observed across racial and ethnic groups. These findings support the use of fecal immunochemical testing in population-based screening strategies.
/Public dissemination. This content from the original organization/authors may be of a point-in-time nature and edited for clarity, style, and length. Mirage.News takes no institutional position or bias, and all views, positions, and conclusions expressed herein are solely those of the author(s). See the full story here.